Fig. 6 | Scientific Reports

Fig. 6

From: Remimazolam attenuated lipopolysaccharide-induced behavioral deficits and neuronal injury via activation of the Nrf2 pathway

Fig. 6

Remimazolam mitigated the decrease of Bcl2, Nrf2 and HO-1 expression in LPS-treated rat hippocampus. (A) The expression of Bcl2, Nrf2 and HO-1 were detected by Western blotting assay and quantified by densitometry. (B–D) The quantification analysis of Bcl2, Nrf2 and HO-1 in the hippocampus. The final statistical results were presented as the ratio of the relative expression of the proteins in the treatment group to the relative expression of the proteins in the Control group. Results are shown as means ± SEM (n = 6). *P < 0.05, **P < 0.01, ***P < 0.001.

Back to article page